CARLSBAD, Calif.-- Invitrogen, maker of research tools for gene cloning and expression, has been granted exclusive worldwide license to market a line of products incorporating Vyrex's reading frame independent epitope tagging technology. Invitrogen will market products for research and development containing Vyrex's Universal DNA, Universal Epitope, or antibodies that recognize the epitope.
Get the full story with
GenomeWeb Premium
Only $95 for the
first 90 days*
GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives
Never miss another important industry story.
Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.
Not ready for premium?
Register for Free ContentYou can still register for access to our free content.